• About
  • Good News
  • Go-Getters
  • Features
  • Long Reads
  • The Spark
    • Op-eds
    • Reviews
    • Other sources of inspiration
  • Solutions Journalism
Start typing and press
Enter to search
  • Facebook
  • Twitter
  • email
  • Instagram
Follow
Skip to content

INKLINE

open search form close search form
  • About
  • Good News
  • Go-Getters
  • Features
  • Long Reads
  • The Spark
    • Op-eds
    • Reviews
    • Other sources of inspiration
  • Solutions Journalism

All articles filed in aducanumab

First drug to slow Alzheimer’s could soon be available

By: Inkline 23 Oct 201925 Oct 2019
Good Newsaducanumab, Alzheimer's, Biogen, dementia, health, researchLeave a Comment on First drug to slow Alzheimer’s could soon be available

The “groundbreaking drug” offers new hope to patients in the early stages.

Read More
Good Newsaducanumab, Alzheimer's, Biogen, dementia, health, researchLeave a Comment on First drug to slow Alzheimer’s could soon be available

Follow us:

  • View mediainkline’s profile on Facebook
  • View TheInkline’s profile on Twitter
  • View TheInkline’s profile on Instagram
  • LinkedIn

INKLINE is an international media platform that features positive news and interviews with go-getters championing sociocultural causes to show the diversity, beauty, and goodness of the world.

Popular Stories

  • What 'Into the Wild' has taught us
  • The Secret Life Of Walter Mitty: Review
  • How Mapuche communities in Chile work toward sustainable agriculture
 

Loading Comments...